新型抗菌药物创新支付方式研究

Study on innovative payment method of new antibacterial drugs

目的梳理各国新型抗菌药物的创新支付方式,为优化我国新型抗菌药物的支付标准提供政策参考。方法对国外适用于新型抗菌药物创新支付方式的国家/地区的相关政策法规进行收集、整理和分析,并探讨为我国所借鉴的可行性。结果美国、英国、法国、德国和瑞典的创新药物支付制度较完善,且均有适用于新型抗菌药物报销的相关政策。结论部分医疗体系发达国家的新型抗菌药物支付方式能够更好地体现新型抗菌药的综合价值,并有效地调动制药企业研发新型抗菌药物的积极性。我国应基于国情,结合国外先进的支付方式,优化我国新型抗菌药物医保支付制度,改进新型抗菌药物医保支付标准,激励更多新药更早的应用于临床。

Objective To investigate the innovative payment methods of new antibacterial drugs in various countries/regions,and to provide policy reference for optimizing the reimbursement system of new antibacterial drugs in China.Methods To search,sort out and analyze,the relevant policies and regulations on the payment methods of new antibacterial drugs in foreign countries/regions were collected and analyzed.Then,the feasibility for using them for reference in China was discussed.Results The payment systems of new drugs in the United States,Britain,France,Germany and Sweden are relatively mature,and all of them have relevant reimbursement policies applicable to new antibacterial drugs.Conclusion The payment methods of new antibacterial drugs in some countries with sound medical systems can better reflect the comprehensive value of new antibacterial drugs and effectively mobilize the enthusiasm of pharmaceutical enterprises to develop new antibacterial drugs.Based on Chinese national conditions and combined with foreign advanced payment methods,we should optimize the medical insurance payment system of new antibacterial drugs,improve the medicare reimbursement standards of new drugs,and encourage more new drugs to be used in clinic earlier.